The Vanguard Group Discloses Stake in Mural Oncology

The Vanguard Group, Inc. has made an opening position disclosure regarding its interest in Mural Oncology plc. As of May 2, 2025, Vanguard reported holding 772,669 ordinary shares of Mural Oncology, representing a 4.47% stake in the company. This disclosure complies with Rule 8.3 of the Irish Takeover Panel Act, 1997, which mandates transparency in dealings involving relevant securities.

The disclosure includes details of a recent transaction on April 5, 2025, where Vanguard sold 36 shares at $2.64 each. The report notes no cash-settled or stock-settled derivative positions associated with Mural Oncology, and there are no agreements related to options or derivatives.

No indemnities or options that might induce dealings have been reported. Additionally, no supplemental Form 8 was filed. This transparency ensures compliance with regulatory requirements for shareholdings exceeding 1% in relevant securities.